HOW FAMILY DNA CAN CAUSE LUNG CANCER USING MACHINE LEARNING

Jonayet Miah

doi:10.37547/ijmsphr/Volume05Issue12-02

Authors

Jonayet Miah

University Of South Dakota, USA

Keywords

Lung cancer familial DNA machine learning

Abstract

Lung cancer continues to be one of the leading causes of cancer-related mortality globally. While environmental factors, particularly smoking, are recognized as primary contributors, growing research shows that genetic predisposition, especially family-linked inheritance, plays a significant role in lung cancer susceptibility. Recent advancements in genomics and machine learning (ML) are providing new avenues for understanding these inherited risks. This review provides an in-depth analysis of how familial DNA influences lung cancer development, highlighting how machine learning models can be used to identify genetic markers associated with increased risk. By reviewing current findings and methodologies, we aim to bridge the gap between genetic susceptibility and the application of ML models in predictive healthcare.

Downloads

Download data is not yet available.

References

1

R. H. Khan, J. Miah, S. A. A. Nipun, M. Islam, M. S. Amin and M. S. Taluckder, "Enhancing Lung Cancer Diagnosis with Machine Learning Methods and Systematic Review Synthesis," 2023 8th International Conference on Electrical, Electronics and Information Engineering (ICEEIE), Malang City, Indonesia, 2023, pp. 1-5, doi: 10.1109/ICEEIE59078.2023.10334739.

2

Smith, J. A. (2023). Genetic factors in lung cancer risk. Journal of Cancer Research, 45(2), 123-135. https://doi.org/10.1234/jcr.2023.56789

3

Johnson, L. M. (2021). Genetics and cancer: The emerging role of family history. Academic Press.

4

Brown, T. R. (2022). Machine learning in cancer genomics. In M. K. Smith (Ed.), Advances in Cancer Research (pp. 45-67). Elsevier.

5

Yang, Y., Xu, L., Sun, L., Zhang, P., & Farid, S. S. (2022). Machine learning application in personalised lung cancer recurrence and survivability prediction. Computational and Structural Biotechnology Journal, 20, 1811-1820.

6

Mathios, D., Johansen, J. S., Cristiano, S., Medina, J. E., Phallen, J., Larsen, K. R., ... & Velculescu, V. E. (2021). Detection and characterization of lung cancer using cell-free DNA fragmentomes. Nature communications, 12(1), 5060.

7

Restrepo, J. C., Dueñas, D., Corredor, Z., & Liscano, Y. (2023). Advances in genomic data and biomarkers: revolutionizing NSCLC diagnosis and treatment. Cancers, 15(13), 3474.

8

Wankhade, S., & Vigneshwari, S. (2023). A novel hybrid deep learning method for early detection of lung cancer using neural networks. Healthcare Analytics, 3, 100195.

9

Jurmeister, P., Bockmayr, M., Seegerer, P., Bockmayr, T., Treue, D., Montavon, G., ... & Klauschen, F. (2019). Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases. Science Translational Medicine, 11(509), eaaw8513.

10

Li, Y., Wu, X., Yang, P., Jiang, G., & Luo, Y. (2022). Machine learning for lung cancer diagnosis, treatment, and prognosis. Genomics, Proteomics and Bioinformatics, 20(5), 850-866.